| Biological Information | |
|---|---|
| Background Information: | CD33 is a myeloid differentiation antigen that is displayed on acute myeloid leukemia (AML) blasts in most patients and, possibly, leukemic stem cells in some, and has thus served as target for antibody-based therapies for many years. CD33 belongs to the sialic acid-binding immunoglobulin lectins (Siglec) family that binds to sialic acid-containing glycans on cell surface glycoproteins and glycolipids on mammalian cells. |
| Target Name: | CD33 |
| Usage | |
| Product Type: | Antibodies |
| Application: | Drug Discovery & Development |
| Storage Conditions: | 4°C. Please avoid multiple freeze/thaw cycles. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Additional Information | |
| Brand: | DiscoverX |
Anti-CD33 Monoclonal Antibody
CD33 is a member of the sialic acid-binding receptor family that is expressed on myeloid cells.
Datasheets
92-1355 Datasheet
View Document